Keith Walcott
Impact in
- Infectious Diseases top 5%
- SARS-CoV-2 detection and testing
- SARS-CoV-2 and COVID-19 Research
- COVID-19 Clinical Research Studies
- Biomedical Engineering top 5%
- Biosensors and Analytical Detection
Papers in
-
- SARS-CoV-2 and COVID-19 Research 4
- SARS-CoV-2 detection and testing 1
-
- Fungal Infections and Studies 2
- Co-authors
- Mélanie Ott (2 shared papers)Jennifer M. Hayashi (2 shared papers)Anita Sil (4 shared papers)Bastian Joehnk (3 shared papers)Andreas S. Puschnik (1 shared paper)Jan E. Carette (1 shared paper)Nevan J. Krogan (1 shared paper)Mehdi Bouhaddou (1 shared paper)
- Journals
- Cell (2 papers)Genome Biology and Evolution (1 paper)Nature Communications (1 paper)PLoS Pathogens (1 paper)PLoS Biology (1 paper)
- Partner nations
- United States
In The Last Decade
Keith Walcott
8 papers receiving 1.2k citations
Peers
Comparison fields: 5 of 72
- Infectious Diseases 530
- Biomedical Engineering 379
- Molecular Biology 486
- Animal Science and Zoology 20
- Bioengineering 5
Countries citing papers authored by Keith Walcott
This map shows the geographic impact of Keith Walcott's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Keith Walcott with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Keith Walcott more than expected).
Fields of papers citing papers by Keith Walcott
This network shows the impact of papers produced by Keith Walcott. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Keith Walcott. The network helps show where Keith Walcott may publish in the future.
Co-authors
The 25 scholars most cited alongside Keith Walcott, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2020 | 829 | |
| 2 | 2020 | 327 | |
| 3 | 2023 | 43 | |
| 4 | 2023 | 8 | |
| 5 | 2025 | 6 | |
| 6 | 2025 | 6 | |
| 7 | 2024 | 5 | |
| 8 | 2025 | 1 |
About Keith Walcott
Keith Walcott is a scholar working on Infectious Diseases, Epidemiology, Molecular Biology, Genetics and Nuclear Energy and Engineering, having authored 8 papers that have together received 1.2k indexed citations. Recurring topics across this work include SARS-CoV-2 and COVID-19 Research (4 papers), Fungal Infections and Studies (2 papers), SARS-CoV-2 detection and testing (1 paper), CRISPR and Genetic Engineering (1 paper), Fungal and yeast genetics research (1 paper) and Genetic diversity and population structure (1 paper). The work is most often cited by research in Infectious Diseases (530 citations), Biomedical Engineering (379 citations), Molecular Biology (486 citations), Animal Science and Zoology (20 citations) and Bioengineering (5 citations). Keith Walcott has collaborated with scholars based in United States. Frequent co-authors include Mélanie Ott, Jennifer M. Hayashi, Anita Sil, Bastian Joehnk, Andreas S. Puschnik, Jan E. Carette, Nevan J. Krogan, Mehdi Bouhaddou, Jared Carlson-Stevermer and Lauren Rodriguez. Their work appears in journals such as Cell, Genome Biology and Evolution, Nature Communications, PLoS Pathogens and PLoS Biology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.